Ligandal, Inc.
PrivateLast Round
Series A
May 1, 2019
Total Funding Raised
$17M
Company Overview
Ligandal, Inc. is a biotechnology company that develops peptide-based delivery technologies for gene therapy, gene editing, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ligandal, Inc. Comparables
Compare Ligandal, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BreezeBio | 84% | |
| NTrans Technologies | 83% | |
| CyGenica | 82% |
Ligandal, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2019 |
Ligandal, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bioverge | Seed |
| Flucas Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2019
$15M round completed.
Ligandal, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ligandal, Inc.'s valuation, stock price, and market status.
Is Ligandal, Inc. a public or private company?
Ligandal, Inc. is a private company.
What is the current stock price of Ligandal, Inc.?
Ligandal, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Ligandal, Inc. worth (valuation)?
Valuation information for Ligandal, Inc. is not publicly available.
Can I buy Ligandal, Inc. stock?
Ligandal, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ligandal, Inc.'s last funding round?
Ligandal, Inc.'s most recent funding round was Series A on May 1, 2019.
Who are the main investors in Ligandal, Inc.?
Key investors in Ligandal, Inc. include Bioverge, Flucas Ventures.
Will Ligandal, Inc. IPO soon?
No public IPO plans have been announced for Ligandal, Inc..
How can I track Ligandal, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ligandal, Inc.'s secondary market activity and sign up for updates.